Deloitte Study: The Economic & Socio Economic benefits of the R&D based multinational pharmaceutical Companies on the South African Economy.
Deloitte Report (Slides) Deloite Report (Document) Sector Fact Sheet
Deloitte Report (Slides)
Deloite Report (Document)
Sector Fact Sheet
IMSA Executive: 2007-2008
Maturin Tchoumi (Roche) - IMSA Chairperson Richard Paulson (Pfizer) - IMSA Vice-Chairperson Jim Ringer (Lilly) Steffan Brygger (MSD) Noel Guliwe (Novartis) John Fagan (Sanofi-Aventis)
Maturin Tchoumi (Roche) - IMSA Chairperson
Richard Paulson (Pfizer) - IMSA Vice-Chairperson
Jim Ringer (Lilly)
Steffan Brygger (MSD)
Noel Guliwe (Novartis)
John Fagan (Sanofi-Aventis)
Media Contact Person:
Val Beaumont - Executive Directive IMSA Email: val@imsa.org.za Tel: 011 880 4644 Fax: 011 880 5987
Val Beaumont - Executive Directive IMSA
Email: val@imsa.org.za
Tel: 011 880 4644
Fax: 011 880 5987
Innovative Medicines SA Val Beaumont
P.O. Box 2008 Houghton, 2041
Tel: +27 11 880-4644
Fax: +27 11 880-5987
Email Us!